Walkers Acting as BVI counsel to Iroko Pharmaceuticals

Walkers is acting in an ongoing capacity as British Virgin Islands law counsel to Iroko Pharmaceuticals, LLC on corporate, commercial and finance matters, as well as providing general law advice.

Recently, Walkers acted as British Virgin Islands law counsel for Iroko Pharmaceuticals in relation to its $140 million debt facility agreement with CRG LP. The new debt facility retired an existing debt facility and provided additional working capital for the company.

Iroko Pharmaceuticals, based in Philadelphia, is a global specialty pharmaceutical company focused on developing and commercialising innovative treatment options for responsible pain management. Through a dynamic, collaborative approach, including the use of novel and proprietary technologies, Iroko develops and commercialises products that help patients manage their pain responsibly. Iroko’s goal is to deliver value to patients, health care professionals, and other stakeholders.